日本大阪大学3月12日发布消息称，针对抗癌药难以起效的癌症，将开始利用“抗体医药”进行临床试验。抗体医药会攻击导致癌症病情恶化的蛋白质。以中后期癌症和难以治愈的乳腺癌患者为实验对象。研究团队成员、大阪大学教授岛津研三表示，“或将大幅改变癌症治疗”。

BEIJING, March 12 (Xinhua) -- China has issued comprehensive guidelines to accelerate the high-quality development of its environmental protection equipment manufacturing sector, targeting global ...

TMTPOST – Shengshu Technology, an AI video company, has appointed Luo Yihang, a former AI executive at ByteDance and head of ...

China is pushing to better align agricultural science and technology with industry needs to enhance productivity and ...